? Deciphera $DCPH has scooped Agios? chief commercial officer Steve Hoerter to fill retiring CEO Michael Taylor?s shoes. The Waltham, MA-based biotech is placing its trust in Hoerter?s sales acumen, especially for cancer drugs, acquired throughout his career at companies like Clovis, Roche, Genentech, Chiron, and Eli Lilly. The first Phase III trial of ripretinib, in gastrointestinal tumors, is due to read out soon.
Peer Review: Anil Singhal assumes leadership of Adicet Bio; Adaptive Biotech woos Genentech vet as CMO
? More than a year after Aya Jakobovits abruptly vacated the CEO office, Adicet Bio has found her permanent successor just ahead of its first IND. Anil Singhal takes over from Donald Santel, the executive chairman who?s been filling the role. An AbbVie… […]
? France?s Innate Pharma has wooed AstraZeneca vet Jennifer Butler to lead the US operations it has set up after acquiring Lumoxiti from the British drugmaker in a rich add-on collaboration deal. Butler?s official title will be EVP and general manager … […]
? Having built out a commercial footprint in the US and led the launch of Bavencio for Merck KGaA, David Trexler is taking up a new role as president of German biotech Morphosys? US subsidiary. Following a dual listing on the Nasdaq $MOR last year, Mor… […]